| Management target | Revenue FY29 |
|---|
| Revenue growth | 31.7% reported overall; 47.1% reported retail growth. |
|---|---|
| Margins | CISR improved by 300 bps to 100.2%. |
| Demand visibility | Strong, specifically in Tier 2/3 towns and retail segments. |
| Management confidence | High; outpacing market growth in retail health. |
Growth
Overall growth at 31.7% (reported); retail health grew 47.1% (reported). Combined Insurance Service Ratio improved to 100.2%.
Outlook
Targeting 8-10% growth above industry average; ROE guidance of mid-to-high teens by FY29; board approved INR 500cr debt raise.
Risks
Challenging pricing environment in the group (B2B) segment resulting in flat growth; potential seasonal impact of infections.
Last quarter's promises, checked
Delivered
- Targeting 25% growth → delivered 31.7% (BEAT)
- ROE double-digit target → delivered 10.7% (BEAT)
- EOM ratio <36% → delivered 35.2% (BEAT)
Partly delivered
- Targeting CISR 99% by FY29 → delivered 100.2% (PARTIAL)
Earnings Call Transcript filed with NSE, NSE: NIVABUPA. Summary written with AI assistance from the document.
Niva Bupa Health Insurance Company Ltd: key numbers
- Share price
- ₹77.08
- Market cap
- ₹14,257 Cr
- Revenue (annual)
- ₹6,695 Cr
- Net profit (annual)
- ₹130.8 Cr
- P/E (TTM)
- 39.6×Sector 21.9×
- Promoter holding
- 55.30%-0.06% QoQ
- FII holding
- 12.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Niva Bupa Health Insurance Company Ltd
All →Niva Bupa Health Insurance Company Credit Rating
Niva Bupa Health Insurance received credit ratings from AM Best, including a Financial Strength Rating of A- and Long-Term Issuer Credit Rating of a-.
Niva Bupa Health Insurance Company Management Change
Niva Bupa Health Insurance announced that Mr. Vikas Jain transitioned to Chief Transformation Officer, while Mr. Karan Bhatia was appointed as the new Chief Investment Officer.
Niva Bupa Health Insurance Company Other Announcement
Niva Bupa received an ESG rating of '67 Leader' for FY24-25 and FY25-26 from Niche99. The rating was assigned independently by the SEBI-registered provider without company engagement.
Niva Bupa Health Insurance Company Employee Stock Options
Niva Bupa Health Insurance allotted 4,11,000 equity shares to employees under its ESOP schemes, increasing the company's total paid-up share capital.
Niva Bupa Health Insurance Company Credit Rating
Niva Bupa Health Insurance received credit rating actions from ICRA, reaffirming its Issuer Rating and assigning a rating to its proposed ₹500 crore subordinated debt issue.
- Value
- ₹500.0 Cr
Niva Bupa Health Insurance Company Legal & Regulatory
IRDAI warned Niva Bupa for non-compliance with Expense of Management limits. The regulator prohibited the company from opening new business locations for six months.
- Execution
- 6 months